These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23320018)

  • 1. Atrioventricular conduction delay in fetuses exposed to anti-SSA/Ro and anti-SSB/La antibodies: a magnetocardiography study.
    Wacker-Gußmann A; Paulsen H; Kiefer-Schmidt I; Henes J; Muenssinger J; Weiss M; Goelz R; Preissl H
    Clin Dev Immunol; 2012; 2012():432176. PubMed ID: 23320018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal magnetocardiography (fMCG) to monitor cardiac time intervals in fetuses at risk for isoimmune AV block.
    Kiefer-Schmidt I; Lim M; Preissl H; Draganova R; Weiss M; Abele H; Kagan KO; Henes J
    Lupus; 2014 Aug; 23(9):919-25. PubMed ID: 24639473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of atrioventricular conduction by echocardiography and magnetocardiography in normal and anti-Ro/SSA-antibody-positive pregnancies.
    Cuneo BF; Bitant S; Strasburger JF; Kaizer AM; Wakai RT
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):625-633. PubMed ID: 30784137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies.
    Askanase AD; Friedman DM; Copel J; Dische MR; Dubin A; Starc TJ; Katholi MC; Buyon JP
    Lupus; 2002; 11(3):145-51. PubMed ID: 11999879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
    Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.
    Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U
    Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrioventricular conduction delay in the second trimester measured by fetal magnetocardiography.
    Wacker-Gussmann A; Paulsen H; Stingl K; Braendle J; Goelz R; Henes J
    J Immunol Res; 2014; 2014():753953. PubMed ID: 24741622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
    Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A
    Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
    Ayed K; Gorgi Y; Sfar I; Khrouf M
    Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses.
    Jaeggi ET; Silverman ED; Laskin C; Kingdom J; Golding F; Weber R
    J Am Coll Cardiol; 2011 Mar; 57(13):1487-92. PubMed ID: 21435519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.
    Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M
    Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block.
    Ivanchenko M; Thorlacius GE; Hedlund M; Ottosson V; Meneghel L; Björkander S; Ossoinak A; Tingström J; Bremme K; Sverremark-Ekström E; Gemzell-Danielsson K; Sonesson SE; Chemin K; Wahren-Herlenius M
    Ann Rheum Dis; 2021 Feb; 80(2):194-202. PubMed ID: 33004330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.
    Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M
    Arthritis Rheum; 2004 Apr; 50(4):1253-61. PubMed ID: 15077309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent fetal sinus bradycardia associated with maternal anti-SSA/Ro and anti-SSB/La antibodies.
    Chockalingam P; Jaeggi ET; Rammeloo LA; Haak MC; Adama van Scheltema PN; Breur JM; Bartelings MM; Clur SA; Blom NA
    J Rheumatol; 2011 Dec; 38(12):2682-5. PubMed ID: 22089457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero.
    Hedlund M; Thorlacius GE; Ivanchenko M; Ottosson V; Kyriakidis N; Lagnefeldt L; Tingström J; Sirsjö A; Bengtsson AA; Aronsson E; Gemzell-Danielsson K; Ronnblom L; Bergman G; Espinosa A; Sonesson SE; Eloranta ML; Wahren-Herlenius M
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
    Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
    J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies.
    Sonesson SE; Ambrosi A; Wahren-Herlenius M
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):87-95. PubMed ID: 30620419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.